Lv4
616 积分 2024-03-31 加入
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports
9天前
已完结
The reporting odds ratio and its advantages over the proportional reporting ratio
9天前
已完结
Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC
15天前
已完结
A pooled analysis of clinical outcome in driver-gene negative non-small cell lung cancer patients with MET overexpression treated with gumarontinib
16天前
已完结
[Analysis of the efficacy and safety of dual immunotherapy in patients with driver gene and programmed death ligand-1 double negative advanced non-small cell lung cancer]
19天前
已完结
Sex differences in renal transporters: assessment and functional consequences
24天前
已完结
Pneumothorax in lung cancer following anlotinib treatment: A case report
29天前
已完结
Combined inhibition of MET and VEGF enhances therapeutic efficacy of EGFR TKIs in EGFR-mutant non-small cell lung cancer with concomitant aberrant MET activation
1个月前
已完结
Pneumothorax in lung cancer following anlotinib treatment: A case report
1个月前
已完结
Primary Lung Cancer Complicated with Pneumothorax
1个月前
已完结
皖公网安备34019202002308
